These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 653722)

  • 41. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. 3. Secondary action of the compounds 31037-S and 31087-S on the preincubated enzyme.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):49-53. PubMed ID: 5771630
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derviatives. I. Active moietes of the compounds 31037-S and 31087-S.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):36-42. PubMed ID: 5771628
    [No Abstract]   [Full Text] [Related]  

  • 43. [Possible change in the substrate specificity of the monoamine oxidase of rat brain and liver mitochondria in hyperoxia].
    Goroshinskaia IA; Bronovitskaia ZG
    Vopr Med Khim; 1976; 22(4):558-62. PubMed ID: 1027243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative alterations in enzymatic properties of amine oxidases.
    Gorkin VZ
    Adv Biochem Psychopharmacol; 1972; 5():55-65. PubMed ID: 4626560
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of lipophilic compounds upon the activity of rat liver mitochondrial monoamine oxidase-A and -B.
    Fowler CJ; Callingham BA; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1980 Apr; 29(8):1177-83. PubMed ID: 7387733
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 47. Activity of some enzymes which synthesize and metabolize catecholamines in the brain and peripheral organs in developing rats.
    Brus R
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):449-57. PubMed ID: 169762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amethocaine-induced inhibition of mitochondrial monoamine oxidase activity.
    Haque SJ; Poddar MK
    J Pharm Pharmacol; 1986 Nov; 38(11):858-60. PubMed ID: 2879023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats.
    Caesar PM; Collins GG; Sandler M
    Biochem Pharmacol; 1970 Mar; 19(3):921-6. PubMed ID: 5507696
    [No Abstract]   [Full Text] [Related]  

  • 50. A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environments.
    Houslay MD
    J Pharm Pharmacol; 1977 Nov; 29(11):664-9. PubMed ID: 22599
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of castration and sex hormones on monoamine oxidase activity in rats].
    Lemay A; Berlinguet L
    Rev Can Biol; 1967 Dec; 26(4):295-303. PubMed ID: 5586168
    [No Abstract]   [Full Text] [Related]  

  • 52. Levels of cytochromes in heart, liver, kidney and brain in the developing rat.
    Hallman M; Mäenpää P; Hassinen I
    Experientia; 1972 Dec; 28(12):1408-10. PubMed ID: 4347401
    [No Abstract]   [Full Text] [Related]  

  • 53. The effects of gamma-irradiation upon monoamine oxidase activity.
    Diaz Borges JM; Drujan BD
    Radiat Res; 1971 Mar; 45(3):589-97. PubMed ID: 5574232
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Transformation" of mitochondrial monoamine oxidase into a diamine oxidase-like enzyme in vitro.
    Gorkin VZ; Tatyanenko LV
    Biochem Biophys Res Commun; 1967 Jun; 27(6):613-7. PubMed ID: 6058807
    [No Abstract]   [Full Text] [Related]  

  • 56. [Liver and heart mitochondrial monoamine oxidase activity in experimental thyrotoxicosis].
    Gorkin VZ; Kandror VI; Krivchenkova RS; Shakhnarovich VM
    Probl Endokrinol (Mosk); 1967; 13(1):64-7. PubMed ID: 5620084
    [No Abstract]   [Full Text] [Related]  

  • 57. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B
    Biochem Pharmacol; 1976 May; 25(10):1133-8. PubMed ID: 938537
    [No Abstract]   [Full Text] [Related]  

  • 58. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzymatic hydrolysis of isocarboxazid by rat tissues.
    Satoh T; Moroi K
    Biochem Pharmacol; 1971 Feb; 20(2):504-7. PubMed ID: 5150150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.